Regulatory T cells require the phosphatase PTEN to maintain suppressive function in homeostatic conditions through preserved expression of CD25 and the transcription factor Foxp3.
References
Josefowicz, S.Z., Lu, L.-F. & Rudensky, A.Y. Annu. Rev. Immunol. 30, 531–564 (2012).
Huynh, A. et al. Nat. Immunol. 16, 188–196 (2015).
Shrestha, S. et al. Nat. Immunol. 16, 178–187 (2015).
Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R. & Farrar, M.A. J. Immunol. 178, 280–290 (2007).
Powell, J.D., Pollizzi, K.N., Heikamp, E.B. & Horton, M.R. Annu. Rev. Immunol. 30, 39–68 (2012).
Michalek, R.D. et al. J. Immunol. 186, 3299–3303 (2011).
Liu, X. et al. J. Clin. Invest. 120, 2497–2507 (2010).
Walsh, P.T. et al. J. Clin. Invest. 116, 2521–2531 (2006).
Bailey-Bucktrout, S.L. et al. Immunity 39, 949–962 (2013).
Lee, S.K. et al. Immunity 37, 880–892 (2012).
Johnston, R.J., Choi, Y.S., Diamond, J.A., Yang, J.A. & Crotty, S. J. Exp. Med. 209, 243–250 (2012).
Kato, H. & Perl, A. J. Immunol. 192, 4134–4144 (2014).
Scalapino, K.J. & Daikh, D.I. PLoS ONE 4, e6031 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ray, J., Craft, J. PTENtiating autoimmunity through Treg cell deregulation. Nat Immunol 16, 139–140 (2015). https://doi.org/10.1038/ni.3082
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3082
- Springer Nature America, Inc.
This article is cited by
-
The new progress in cancer immunotherapy
Clinical and Experimental Medicine (2022)
-
The functions of tumor suppressor PTEN in innate and adaptive immunity
Cellular & Molecular Immunology (2017)
-
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Nature Reviews Rheumatology (2016)